![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Neuropharm | LSE:NPH | London | Ordinary Share | GB00B1NPJJ01 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
| At 30 June | 3,154 | 17,269 | (607) | - | 632 | (7,790) | 12,658 | | 2008 | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Share option | - | - | - | - | 308 | - | 308 | | expense | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Reserve | - | - | - | - | - | - | - | | transfer | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Total | - | - | - | - | - | (3,458) | (3,458) | | comprehensive | | | | | | | | | loss for the | | | | | | | | | period | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | At 31 December | 3,154 | 17,269 | (607) | - | 940 | (11,248) | 9,508 | | 2008 | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Share option | - | - | - | - | 142 | - | 142 | | expense | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Foreign | - | - | - | 33 | - | - | 33 | | exchange | | | | | | | | | adjustments on | | | | | | | | | consolidation | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Total | - | - | - | - | - | (2,426) | (2,426) | | comprehensive | | | | | | | | | loss for the | | | | | | | | | period | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | At 30 June | 3,154 | 17,269 | (607) | 33 | 1,082 | (13,674) | 7,257 | | 2009 | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Share option | - | - | - | - | 91 | - | 91 | | expense | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Foreign | - | - | - | 4 | - | - | 4 | | exchange | | | | | | | | | adjustments on | | | | | | | | | consolidation | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | Total | - | - | - | - | - | (1,225) | (1,225) | | comprehensive | | | | | | | | | loss for the | | | | | | | | | period | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ | At 31 December | 3,154 | 17,269 | (607) | 37 | 1,173 | (14,899) | 6,127 | | 2009 | | | | | | | | +----------------+---------+---------+---------+-------------+--------------+----------+---------+ +------------------------------------+------+--+----------+----------+----------+ | | | Consolidated Balance Sheet | | Six months ended 31 December 2009 | | | +-------------------------------------------------------------------------------+ | |Note | | 31 Dec | 31 Dec | 30 | | | | | 2009 | 2008 | June | | | | | GBP'000 | GBP'000 | 2009 | | | | | | | GBP'000 | +------------------------------------+------+--+----------+----------+----------+ | | | | | | | +------------------------------------+------+--+----------+----------+----------+ | Non-current assets | | | | | | +------------------------------------+------+--+----------+----------+----------+ | Intangible assets | 6 | | - | - | - | +------------------------------------+------+--+----------+----------+----------+ | Property, plant and equipment | 7 | | 11 | 16 | 16 | +------------------------------------+------+--+----------+----------+----------+ | | | | 11 | 16 | 16 | +------------------------------------+------+--+----------+----------+----------+ | Current assets | | | | | | +------------------------------------+------+--+----------+----------+----------+ | Accrued income and margin deposits | | | - | 180 | 63 | +------------------------------------+------+--+----------+----------+----------+ | Trade and other receivables | | | 145 | 182 | 95 | +------------------------------------+------+--+----------+----------+----------+ | Derivative financial instruments | | | - | 150 | - | +------------------------------------+------+--+----------+----------+----------+ | Research and development tax credits | | - | - | 600 | | receivable | | | | | +-------------------------------------------+--+----------+----------+----------+ | Money market investments | | | - | 6,500 | 1,000 | +------------------------------------+------+--+----------+----------+----------+ | Cash and cash equivalents | | | 6,182 | 3,676 | 6,037 | +------------------------------------+------+--+----------+----------+----------+ | | | | 6,327 | 10,688 | 7,795 | +------------------------------------+------+--+----------+----------+----------+ | Current liabilities | | | | | | +------------------------------------+------+--+----------+----------+----------+ | Trade and other payables | | | (211) | (1,144) | (554) | +------------------------------------+------+--+----------+----------+----------+ | Net current assets | | | 6,116 | 9,544 | 7,241 | +------------------------------------+------+--+----------+----------+----------+ | Total assets less current | | | 6,127 | 9,560 | 7,257 | | liabilities | | | | | | +------------------------------------+------+--+----------+----------+----------+ | | | | | | | +------------------------------------+------+--+----------+----------+----------+
1 Year Neuropharm Chart |
1 Month Neuropharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions